NVO Novo Nordisk A/S Stock Quote

NVO [NYSE]

Healthcare | Drug Manufacturers - General | Denmark

Index	-	P/E	34.61	EPS (ttm)	3.03	Insider Own	26.40%	Shs Outstand	2.27B	Perf Week	-2.51%
Market Cap	184.65B	Forward P/E	3.67	EPS next Y	28.56	Insider Trans	0.00%	Shs Float	1.08B	Perf Month	-9.51%
Income	6.94B	PEG	17.39	EPS next Q	6.01	Inst Own	8.30%	Short Float	0.12%	Perf Quarter	-1.44%
Sales	21.60B	P/S	8.55	EPS this Y	15.20%	Inst Trans	0.11%	Short Ratio	0.88	Perf Half Y	3.40%
Book/sh	4.51	P/B	23.24	EPS next Y	20.03%	ROA	25.80%	Target Price	128.20	Perf Year	-0.11%
Cash/sh	2.42	P/C	43.31	EPS next 5Y	1.99%	ROE	72.80%	52W Range	91.51 - 122.16	Perf YTD	-6.42%
Dividend	1.61	P/FCF	38.24	EPS past 5Y	6.70%	ROI	48.60%	52W High	-16.18%	Beta	0.45
Dividend %	1.53%	Quick Ratio	0.70	Sales past 5Y	4.70%	Gross Margin	83.90%	52W Low	11.90%	ATR	3.01
Employees	50816	Current Ratio	0.90	Sales Q/Q	24.90%	Oper. Margin	42.20%	RSI (14)	37.82	Volatility	1.68% 2.51%
Optionable	Yes	Debt/Eq	0.34	EPS Q/Q	11.30%	Profit Margin	32.10%	Rel Volume	0.83	Prev Close	104.81
Shortable	Yes	LT Debt/Eq	0.32	Earnings	Aug 03 BMO	Payout	357.20%	Avg Volume	1.48M	Price	102.40
Recom	1.30	SMA20	-6.80%	SMA50	-7.08%	SMA200	-5.53%	Volume	782,443	Change	-2.30%

Jul-15-22

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Jun-28-22

Downgrade

UBS

Neutral → Sell

Jun-27-22

Upgrade

Exane BNP Paribas

Underperform → Neutral

Jun-07-22

Upgrade

JP Morgan

Neutral → Overweight

May-31-22

Upgrade

Guggenheim

Neutral → Buy

Apr-25-22

Upgrade

Cowen

Market Perform → Outperform

$130

Apr-12-22

Upgrade

Morgan Stanley

Underweight → Equal-Weight

Mar-16-22

Upgrade

Deutsche Bank

Hold → Buy

Jan-25-22

Downgrade

Liberum

Hold → Sell

Dec-20-21

Downgrade

JP Morgan

Overweight → Neutral

Dec-17-21

Downgrade

Deutsche Bank

Buy → Hold

Jan-20-21

Downgrade

Credit Suisse

Outperform → Neutral

Jan-15-21

Initiated

Deutsche Bank

Buy

Sep-29-20

Initiated

Berenberg

Hold

Jul-06-20

Downgrade

BofA Securities

Buy → Neutral

May-11-20

Downgrade

UBS

Buy → Neutral

May-04-20

Initiated

Cowen

Market Perform

$72

Mar-16-20

Upgrade

BofA/Merrill

Neutral → Buy

Jan-03-20

Downgrade

Guggenheim

Buy → Neutral

Nov-18-19

Upgrade

Barclays

Equal Weight → Overweight

Aug-17-22 11:56PM	Is Novo Nordisk (NVO) a Smart Long-Term Investment? Insider Monkey
10:00AM	How Eli Lilly Is Thinning Out the Competition Motley Fool
Aug-15-22 08:19AM	Novo Nordisk A/S: Share repurchase programme GlobeNewswire
Aug-14-22 11:09AM	10 Healthcare Stocks to Watch Amid Senates Healthcare Bill Insider Monkey
Aug-13-22 06:11AM	3 Stocks to Buy and Hold Forever Motley Fool
Aug-12-22 09:10PM	At Last, Weight-Loss Drugs That Actually Work. They Could Be the Blockbusters of the Decade. Barrons.com
Aug-09-22 10:37AM	Prothena (PRTA) Q2 Earnings Miss, Pipeline Progress in Focus Zacks
Aug-08-22 11:06AM	Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons GlobeNewswire
Aug-05-22 11:13AM	Quest to Cut Prescription Drug Prices Puts Insulin in Spotlight Investing.com
09:32AM	Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons GlobeNewswire
05:30AM	New Weight-Loss Drugs Can Fatten Drugmakers Profits The Wall Street Journal
Aug-04-22 03:01PM	12 Best Healthcare Stocks To Buy Now Insider Monkey
12:26PM	Novo Nordisk's (NVO) Q2 Earnings Miss, Sales Beat Estimates Zacks
10:00AM	Novo Nordisk (NVO) Q2 2022 Earnings Call Transcript Motley Fool
05:40AM	Obesity drug supply delay not unusual says Novo Nordisk CEO Reuters
Aug-03-22 04:01PM	Novo Nordisk's Obesity Sales Nearly Doubled, But That Wasn't Enough For NVO Stock Investor's Business Daily -12.71%
02:01PM	Novo Nordisk Shares Fall After Q2 Earnings Despite Raised Annual Outlook Benzinga
10:39AM	Novo Nordisk shares fall on Wegovy news despite outlook lift Reuters
10:36AM	Novo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022 GlobeNewswire
10:21AM	Novo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022 GlobeNewswire
09:48AM	Drug, Biotech Stocks' Q2 Earnings on Aug 4: LLY, AMGN & More Zacks
05:43AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Aug-01-22 12:07PM	Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards? Zacks
10:08AM	Health care bill most aggressive action on drug pricing: Analyst Yahoo Finance Video
Jul-31-22 07:00AM	U.S. Would Gain Power to Negotiate Drug Prices Under Manchin-Schumer Bill The Wall Street Journal
Jul-29-22 01:42PM	Novo Nordisk Once-Weekly Insulin Hits Primary Goals In In Two Phase 3 Trials Benzinga
07:43AM	Novo Nordisk achieves primary objectives of ONWARDS 3 and 4 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin degludec in ONWARDS 3 GlobeNewswire
Jul-25-22 07:04AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jul-23-22 12:15PM	Heres What Makes Novo Nordisk (NVO) an Interesting Investment Option Insider Monkey
Jul-22-22 11:30AM	2 Pharma Giants With Momentum That Could Carry Through 2030 Motley Fool
Jul-19-22 06:40AM	The Zacks Analyst Blog Highlights AMN Healthcare, Boeing, Clorox, Novo Nordisk and Costco Wholesale Zacks
Jul-18-22 05:39PM	Coal Stocks Today: Why Alliance Resource Partners Remains A Stock Market Leader Investor's Business Daily
06:34AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jul-15-22 11:43AM	Marinus (MRNS) to Sell Rare Disease PRV to Novo Nordisk Zacks
Jul-14-22 11:07AM	Marinus selling rare pediatric disease priority review voucher for $110M American City Business Journals
09:11AM	Marinus to sell rare-disease voucher to Novo Nordisk for $110 million MarketWatch
12:00AM	A new miracle weight-loss drug really works raising huge questions Financial Times
Jul-12-22 11:13AM	Novo Nordisk's (NVO) Haemophilia A Study Meets Safety Endpoint Zacks
09:54AM	IBD Screen Of The Day: Mutual Funds Are Buying These Energy Stocks Investor's Business Daily
Jul-11-22 02:23PM	California's plan to manufacture cheap insulin: What we know so far Yahoo Finance
01:24PM	With New Phase 3 Data From Its Hemophilia Study, Novo Nordisk Plots Route To FDA Benzinga
12:52PM	Novo Nordisk's Mim8 Shows Potential As Once Monthly Treatment For Hemophilia A Benzinga
11:45AM	Henry Schein's (HSIC) New Buyout Expands Its Switzerland Base Zacks
09:45AM	Novo Nordisk A/S: Mim8 phase 1 & 2 data demonstrates potential as once monthly treatment for people with haemophilia A GlobeNewswire
06:41AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jul-10-22 10:02AM	Novo Nordisk A/S: Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors GlobeNewswire
Jul-08-22 11:44AM	Chinook (KDNY) Stock Rallies 24.2% in 3 Months: Here's Why Zacks
11:31AM	LabCorp's (LH) Base Testing Volume Grows, Costs Rise Zacks
11:14AM	Here's Why You Should Retain Haemonetics (HAE) Stock For Now Zacks
Jul-07-22 11:58AM	Merck (MRK) in Advanced Talks to Buy Seagen (SGEN) Per WSJ Zacks
11:34AM	Bruker (BRKR) Debuts NMR Test for Research on Long COVID Risks Zacks
Jul-06-22 01:15PM	Here's Why You Should Retain Edwards Lifesciences (EW) Now Zacks
01:04PM	Reasons Why You Should Invest in ResMed (RMD) Stock Now Zacks
09:15AM	Biogen (BIIB) Lecanemab Gets FDA Priority Tag for Alzheimer's Zacks
09:13AM	Tandem Diabetes (TNDM) New Launches Aid Growth Amid Cost Woes Zacks
09:03AM	Bruker (BRKR) International Growth Strong Amid Competition Zacks
08:00AM	The Zacks Analyst Blog Highlights Novo Nordisk, Intel, Qualcomm, T-Mobile US and Sony Group Zacks
Jul-05-22 12:56PM	Here's Why Investors Should Retain Charles River (CRL) Now Zacks
12:13PM	Top Analyst Reports for Novo Nordisk, Intel & Qualcomm Zacks
10:16AM	AstraZeneca (AZN) to Buy TeneoTwo, Boost Hematology Pipeline Zacks
10:00AM	Best Momentum Stocks to Buy for July 5th Zacks
07:51AM	New Strong Buy Stocks for July 5th Zacks
Jul-04-22 12:45PM	Looking for a Growth Stock? 3 Reasons Why Novo Nordisk (NVO) is a Solid Choice Zacks
12:25PM	LabCorp (LH) to Strengthen Laboratory Footprint in Japan Zacks
10:34AM	NuVasive (NUVA) to Expand in APAC With New Experience Center Zacks
08:54AM	Novo Nordisk A/S: Share repurchase programme GlobeNewswire
Jul-02-22 11:15AM	2 Safe Stocks That Can Survive Any Downturn Motley Fool
Jul-01-22 11:45AM	Sanofi's (SNY) Studies on BTK Inhibitor Put on Hold by FDA Zacks
11:03AM	Here's Why Investors Should Retain STERIS (STE) Stock for Now Zacks
10:33AM	Quest Diagnostics' (DGX) Base Business Grows Despite Margin Woes Zacks
10:00AM	Ken Fisher Loves These 10 Defensive Stocks Insider Monkey
Jun-30-22 10:20AM	Exact Sciences (EXAS) Cologuard Growth Robust Amid Margin Woes Zacks
Jun-29-22 12:41PM	Omnicell (OMCL) Up 10% Since Q1 Earnings: What's Driving It? Zacks
12:39PM	Illumina's (ILMN) GRAIL to Offer Galleri Test in Indianapolis Zacks
09:23AM	Align (ALGN) Gains From Increased Case Shipment Amid FX Woes Zacks
09:17AM	4 Reasons Why Investors Should Buy Merck (MRK) Stock Now Zacks
Jun-28-22 01:08PM	Charles River (CRL) Signs saRNA-Based Vaccine Manufacture Deal Zacks
01:06PM	Here's Why Investors Should Retain Syneos Health (SYNH) For Now Zacks
12:15PM	Stock Market Losses Deepen At Midday; Cereal Maker's Breakout Falters Investor's Business Daily
10:14AM	Sanofi (SNY) Wins Nod for Nexviadyme & Xenpozyme in Europe Zacks
Jun-27-22 12:38PM	Here's Why Investors Should Retain CVS Health (CVS) For Now Zacks
11:55AM	Novartis (NVS) Gets Positive CHMP Opinion for Scemblix in CML Zacks
11:08AM	AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication Zacks
11:01AM	Investors are Watching These 10 Biotech Stocks Insider Monkey
09:02AM	Merck (MRK) Keytruda Gets Europe Nod for Expanded Melanoma Use Zacks
07:29AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jun-24-22 10:16AM	ESG Investing: 7 Profitable Stock Picks for the Socially Responsible InvestorPlace
Jun-23-22 08:00AM	Camp Huronda welcomes back campers for a long-awaited reopening and unveils the new Insul-Inn CNW Group
Jun-20-22 08:44AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jun-17-22 12:45PM	3 Reasons Why Novo Nordisk (NVO) Is a Great Growth Stock Zacks
Jun-15-22 08:25AM	Is Novo Nordisk (NVO) a Smart Long-Term Investment? Insider Monkey
Jun-13-22 09:00AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jun-12-22 12:31PM	Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency GlobeNewswire
Jun-11-22 09:42AM	Theres No Miracle Cure for Obesityor Is There? Barrons.com
Jun-10-22 06:26PM	Your Weight Loss Could Be Eli Lilly and Novo Nordisks Gain Barrons.com
09:36AM	These 2 High-Growth Stocks Could Power the Bull Market's Next Record Run Motley Fool
09:05AM	The Zacks Analyst Blog Highlights Novo Nordisk, Toyota Motor, Salesforce, Abbott Laboratories, Raytheon Technologies, and Equinor Zacks
08:00AM	We're Looking At Obesity In A New Way And 4 Pharmaceutical Stocks Could Benefit Investor's Business Daily
Jun-09-22 11:41AM	Top Research Reports for Novo Nordisk, Toyota & Salesforce Zacks
08:30AM	Here's How Much a $1000 Investment in Novo Nordisk Made 10 Years Ago Would Be Worth Today Zacks

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience